google-site-verification: googlec7193c3de77668c9.html
Tuesday , September 22 2026

Tag Archives: prove

Novel endocrine therapy improves disease-free survival over standard of care for patients with early-stage breast cancer

[ The investigational, oral selective estrogen receptor degrader (SERD) giredestrant given as an adjuvant therapy showed significant improvement in invasive disease-free survival (iDFS) compared with the current standard-of-care endocrine therapy in patients with early-stage, hormone receptor (HR)-positive, HER2-negative breast cancer, according to the results of a Phase III IidERA trial …

Read More »

Recent Comments